Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Wasserman

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Pediatric Radiology|September 29, 2000
Cephaloskeletal dysplasia (Taybi-Linder syndrome: osteodysplastic primordial dwarfism type III): report of two cases and review of the literatureG F Vichi, G Currarino, R L Wasserman, et al.
Pediatric Dermatology|September 1, 1986
Ataxia-telangiectasia associated with sarcoidosisR M Fleck, L K Myers, R L Wasserman, et al.
The Journal of Pediatrics|December 1, 1983
Transfusion-associated cytomegalovirus infection and acquired immune deficiency syndrome in an infantK Shannon, E Ball, R L Wasserman, et al.
The Journal of Clinical Investigation|May 1, 1988
Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic familyM M Newkirk, H Gram, G F Heinrich, et al.
International Journal of Clinical Practice|September 20, 2006
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfactionK Sheth, R L Wasserman, W R Lincourt, et al.
Clinical and Experimental Immunology|November 4, 2009
Subcutaneous immunoglobulin: opportunities and outlookS Misbah, M H Sturzenegger, M Borte, et al.
Clinical and Experimental Immunology|June 17, 2010
Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency diseaseR L Wasserman, A-M Irani, J Tracy, et al.
Clinical and Experimental Immunology|July 11, 2012
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapyJ S Orange, B H Belohradsky, M Berger, et al.
Pediatrics|February 1, 1990
Lack of transmission of human immunodeficiency virus from infected children to their household contactsM F Rogers, C R White, R Sanders, et al.
Allergy|September 3, 2011
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 studyT J Craig, A K Bewtra, S L Bahna, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pediatric Radiology|September 29, 2000
Cephaloskeletal dysplasia (Taybi-Linder syndrome: osteodysplastic primordial dwarfism type III): report of two cases and review of the literatureG F Vichi, G Currarino, R L Wasserman, et al.
Pediatric Dermatology|September 1, 1986
Ataxia-telangiectasia associated with sarcoidosisR M Fleck, L K Myers, R L Wasserman, et al.
The Journal of Pediatrics|December 1, 1983
Transfusion-associated cytomegalovirus infection and acquired immune deficiency syndrome in an infantK Shannon, E Ball, R L Wasserman, et al.
The Journal of Clinical Investigation|May 1, 1988
Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic familyM M Newkirk, H Gram, G F Heinrich, et al.
International Journal of Clinical Practice|September 20, 2006
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfactionK Sheth, R L Wasserman, W R Lincourt, et al.
Clinical and Experimental Immunology|November 4, 2009
Subcutaneous immunoglobulin: opportunities and outlookS Misbah, M H Sturzenegger, M Borte, et al.
Clinical and Experimental Immunology|June 17, 2010
Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency diseaseR L Wasserman, A-M Irani, J Tracy, et al.
Clinical and Experimental Immunology|July 11, 2012
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapyJ S Orange, B H Belohradsky, M Berger, et al.
Pediatrics|February 1, 1990
Lack of transmission of human immunodeficiency virus from infected children to their household contactsM F Rogers, C R White, R Sanders, et al.
Allergy|September 3, 2011
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 studyT J Craig, A K Bewtra, S L Bahna, et al.
Pageof 3